John Brian Mumm
37Patents
11h-index
7Co-inventors
64Inventor score
Filing activity: Dec 22, 2010 → Nov 3, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10981965B2 | IL-10 variant molecules and methods of treating inflammatory disease | Emerging Cross-Sectional Technologies | 20 | Active |
| US10858412B2 | Antibody variable domain regions fused to IL-10 variant molecules | Emerging Cross-Sectional Technologies | 20 | Active |
| US10981966B2 | IL-10 variant molecules conjugated with antibody variable domain regions | Emerging Cross-Sectional Technologies | 20 | Active |
| US11292822B2 | Dual cytokine fusion proteins comprising IL-10 | Chemistry; Metallurgy | 18 | Active |
| US10975133B2 | Methods for treating malignant tumors with IL-10 variant conjugates | Emerging Cross-Sectional Technologies | 18 | Active |
| US10975134B2 | Antibody-IL-10 fusion proteins | Emerging Cross-Sectional Technologies | 18 | Active |
| US11613563B2 | Dual cytokine fusion proteins comprising IL-10 | Chemistry; Metallurgy | 13 | Active |
| US11608368B2 | Dual cytokine fusion proteins comprising IL-10 | Chemistry; Metallurgy | 13 | Active |
| US11618775B2 | Dual cytokine fusion proteins comprising IL-10 | Chemistry; Metallurgy | 13 | Active |
| US11572397B2 | Dual cytokine fusion proteins comprising IL-10 | Chemistry; Metallurgy | 13 | Active |
| US11629178B2 | Dual cytokine fusion proteins comprising IL-10 | Chemistry; Metallurgy | 13 | Active |
| US8865652B2 | Method of treating solid cancers with pegylated IL-10 | Chemistry; Metallurgy | 5 | Active |
| US9364517B2 | Method of treatment of lymphoma with pegylated IL-10 | Chemistry; Metallurgy | 5 | Active |
| US10195274B2 | Method of modulating a chimeric antigen receptor t cell immune response by administering IL-10 | Chemistry; Metallurgy | 3 | Active |
| US12116392B2 | Dual cytokine fusion proteins comprising IL-10 | Chemistry; Metallurgy | 2 | Active |
| US12116389B2 | Dual cytokine fusion proteins comprising IL-10 | Chemistry; Metallurgy | 2 | Active |
| US12145007B2 | Dual cytokine fusion proteins comprising IL-10 | Chemistry; Metallurgy | 2 | Active |
| US12122814B2 | Dual cytokine fusion proteins comprising IL-10 | Chemistry; Metallurgy | 2 | Active |
| US12006346B2 | Dual cytokine fusion proteins comprising IL-10 | Chemistry; Metallurgy | 2 | Active |
| US12121755B2 | Dual cytokine fusion proteins comprising IL-10 | Chemistry; Metallurgy | 2 | Active |
| US12116393B2 | Dual cytokine fusion proteins comprising IL-10 | Chemistry; Metallurgy | 2 | Active |
| US12116391B2 | Dual cytokine fusion proteins comprising IL-10 | Chemistry; Metallurgy | 2 | Active |
| US12116390B2 | Dual cytokine fusion proteins comprising IL-10 | Chemistry; Metallurgy | 2 | Active |
| US12110317B2 | Dual cytokine fusion proteins comprising IL-10 | Chemistry; Metallurgy | 2 | Active |
| US9833514B2 | Use of pegylated IL-10 to treat cancer | Chemistry; Metallurgy | 1 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.